BioCentury | Mar 29, 2021
Product Development

March 29 Quick Takes: Humanigen mAb meets COVID endpoint; plus Merck, Wave, Celldex, Ionis, Orphazyme and uniQure

...Staff IONIS-PKK-LRx CDX-0159 arimoclomol (BRX-345, OR-01) etranacogene dezaparvovec, AMT-061 Keytruda, pembrolizumab (MK-3475, lambrolizumab) Ionis Pharmaceuticals Celldex...
BioCentury | Mar 23, 2021
Product Development

March 22 Quick Takes: Ionis falls as Genentech halts Huntington’s trial; plus Pfizer, Evotec-Takeda, Everest, BioCryst and Odonate

...program’s benefit-risk profile. Genentech, which has rights to the antisense molecule targeting huntingtin protein from Ionis Pharmaceuticals Inc....
BioCentury | Mar 12, 2021
Product Development

Korea Spotlight: How OliX is spreading its siRNA beyond Korea’s borders

...Chemicals LLC, which was founded in 2003 by Ionis Pharmaceuticals Inc....
BioCentury | Mar 6, 2021
Product Development

The pace of new modality approvals is picking up

...designation. Antisense drugs have been dominated by two companies, Ionis Pharmaceuticals Inc....
BioCentury | Mar 5, 2021
Translation in Brief

A stem cell therapy for brain metastases in breast cancer; plus a nanoparticle gene editing delivery tech and more

...CpG binding protein 2 Danielle Golovin Harvard Medical School Amasa Therapeutics Tufts University Broad Institute of MIT and Harvard Editas Medicine Inc. Ionis Pharmaceuticals Inc. Baylor...
BioCentury | Feb 13, 2021
Product Development

Howdy partner: MD Anderson’s evolving industry collaboration strategy

...hoc way,” he said. “We do translational work to the full extent that the science allows.”Ionis Pharmaceuticals Inc....
BioCentury | Feb 6, 2021
Product Development

Genmab’s strategy for going commercial

...start, Genmab’s path is more akin to 32-year-old Ionis Pharmaceuticals Inc....
BioCentury | Jan 30, 2021
Product Development

ALS looks up as clinical pipeline explodes

...caps in ALS. Through its partnership with Ionis Pharmaceuticals Inc....
...treat the disease via T cells. Selina Koch Biogen Inc. Ionis Pharmaceuticals Inc. Novartis...
BioCentury | Jan 23, 2021
Translation in Brief

Ionis’ ASO therapy for MM; plus epigenetic modification prevents myeloma-associated bone loss and bryostatin analogs reduce neuroinflammation

...Golovin, Staff Writer Ionis’ antisense oligonucleotide therapy prevents malignant myeloma regenerationUniversity of California San Diego and Ionis Pharmaceuticals Inc....
...N-methyltransferase 2 IRF4 – Interferon regulatory factor 4PKC – Protein kinase C Danielle Golovin University of California San Diego Ionis Pharmaceuticals Inc. Bellvitge...
BioCentury | Jan 8, 2021
Management Tracks

PacBio hires pair of Illumina vets; plus Ionis, Sana, Purespring, eFFECTOR, Constellation, T2, MiNA, Vividion, Pharma Two B and WIB

...chief commercial officer, and Fromen was most recently global VP of population genomics and precision health.Ionis Pharmaceuticals Inc....
...and sponsorship (MAPS) program and as chair of its Research Triangle Park, N.C., chapter. BC Staff Purespring Therapeutics Ionis Pharmaceuticals Inc. Constellation...
Items per page:
1 - 10 of 1442
BioCentury | Mar 29, 2021
Product Development

March 29 Quick Takes: Humanigen mAb meets COVID endpoint; plus Merck, Wave, Celldex, Ionis, Orphazyme and uniQure

...Staff IONIS-PKK-LRx CDX-0159 arimoclomol (BRX-345, OR-01) etranacogene dezaparvovec, AMT-061 Keytruda, pembrolizumab (MK-3475, lambrolizumab) Ionis Pharmaceuticals Celldex...
BioCentury | Mar 23, 2021
Product Development

March 22 Quick Takes: Ionis falls as Genentech halts Huntington’s trial; plus Pfizer, Evotec-Takeda, Everest, BioCryst and Odonate

...program’s benefit-risk profile. Genentech, which has rights to the antisense molecule targeting huntingtin protein from Ionis Pharmaceuticals Inc....
BioCentury | Mar 12, 2021
Product Development

Korea Spotlight: How OliX is spreading its siRNA beyond Korea’s borders

...Chemicals LLC, which was founded in 2003 by Ionis Pharmaceuticals Inc....
BioCentury | Mar 6, 2021
Product Development

The pace of new modality approvals is picking up

...designation. Antisense drugs have been dominated by two companies, Ionis Pharmaceuticals Inc....
BioCentury | Mar 5, 2021
Translation in Brief

A stem cell therapy for brain metastases in breast cancer; plus a nanoparticle gene editing delivery tech and more

...CpG binding protein 2 Danielle Golovin Harvard Medical School Amasa Therapeutics Tufts University Broad Institute of MIT and Harvard Editas Medicine Inc. Ionis Pharmaceuticals Inc. Baylor...
BioCentury | Feb 13, 2021
Product Development

Howdy partner: MD Anderson’s evolving industry collaboration strategy

...hoc way,” he said. “We do translational work to the full extent that the science allows.”Ionis Pharmaceuticals Inc....
BioCentury | Feb 6, 2021
Product Development

Genmab’s strategy for going commercial

...start, Genmab’s path is more akin to 32-year-old Ionis Pharmaceuticals Inc....
BioCentury | Jan 30, 2021
Product Development

ALS looks up as clinical pipeline explodes

...caps in ALS. Through its partnership with Ionis Pharmaceuticals Inc....
...treat the disease via T cells. Selina Koch Biogen Inc. Ionis Pharmaceuticals Inc. Novartis...
BioCentury | Jan 23, 2021
Translation in Brief

Ionis’ ASO therapy for MM; plus epigenetic modification prevents myeloma-associated bone loss and bryostatin analogs reduce neuroinflammation

...Golovin, Staff Writer Ionis’ antisense oligonucleotide therapy prevents malignant myeloma regenerationUniversity of California San Diego and Ionis Pharmaceuticals Inc....
...N-methyltransferase 2 IRF4 – Interferon regulatory factor 4PKC – Protein kinase C Danielle Golovin University of California San Diego Ionis Pharmaceuticals Inc. Bellvitge...
BioCentury | Jan 8, 2021
Management Tracks

PacBio hires pair of Illumina vets; plus Ionis, Sana, Purespring, eFFECTOR, Constellation, T2, MiNA, Vividion, Pharma Two B and WIB

...chief commercial officer, and Fromen was most recently global VP of population genomics and precision health.Ionis Pharmaceuticals Inc....
...and sponsorship (MAPS) program and as chair of its Research Triangle Park, N.C., chapter. BC Staff Purespring Therapeutics Ionis Pharmaceuticals Inc. Constellation...
Items per page:
1 - 10 of 1442